(Q39037107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Child developmental outcomes in preschool children following antidepressant exposure in pregnancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Megan Galbally

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Anne Buist

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

19 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

642-650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25698806%20AND%20SRC:MED&resulttype=core&format=json

The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Use of antidepressant medications during pregnancy: a multisite study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Characteristics of people lost to attrition in psychiatric follow-up studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Developmental outcomes of children exposed to antidepressants in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Assessment of executive function in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Early life programming as a target for prevention of child and adolescent mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Neurodevelopment of children exposed in utero to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Antenatal anxiety predicts child behavioral/emotional problems independently of postnatal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

The Norwegian Institute of Public Health twin study of mental health: examining recruitment and attrition bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Prevalence and patterns of antidepressant drug use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800

Neonatal Growth Outcomes at Birth and one Month Postpartum Following In Utero Exposure to Antidepressant Medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415569800